Early low-dose ghrelin intervention via miniosmotic pumps could protect against the progressive dopaminergic neuron loss in Parkinson's disease mice

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596 · see citing works

Ghrelin induces adiposity in rodents

Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000) · Nature · doi:10.1038/35038090 · Cited by 3,949 · see citing works

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · see citing works

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion.

Shiiya, T., Nakazato, M., Mizuta, M., Date, Y., Mondal, M. S., Tanaka, M., Nozoe, S., Hosoda, H., Kangawa, K., & Matsukura, S. (2002) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.87.1.8129 · Cited by 1,390 · see citing works

Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein

Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266 · see citing works

Role of neuroinflammation in neurodegenerative diseases (Review)

Chen, W., Zhang, X., & Huang, W. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4948 · Cited by 933 · see citing works

Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia Nigra

Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845 · see citing works

Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice

Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., & Price, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132197599 · Cited by 824 · see citing works

Expression of A53T Mutant But Not Wild-Type α-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death

Stefanis, L., Larsen, K. E., Rideout, H. J., Sulzer, D. L., & Greene, L. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09549.2001 · Cited by 569 · see citing works

Systemic Administration of Ghrelin Induces Fos and Egr‐1 Proteins in the Hypothalamic Arcuate Nucleus of Fasted and Fed Rats

Hewson, A. K., & Dickson, S. L. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00584.x · Cited by 357 · see citing works

Association of circulating TNF-α and IL-6 with ageing and parkinsonism

Dobbs, R. J., Charlett, A., Purkiss, A. G., Dobbs, S. M., Weller, C., & Peterson, D. W. (1999) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00721.x · Cited by 324 · see citing works

An inflammatory review of Parkinson's disease

Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309 · see citing works

Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism

Andrews, Z. B., Erion, D., Beiler, R., Liu, Z.-W., Abizaid, A., Zigman, J., Elsworth, J. D., Savitt, J. M., DiMarchi, R., Tschöp, M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3890-09.2009 · Cited by 289 · see citing works

Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation

Lázaro, D. F., Rodrigues, E. F., Langohr, R., Shahpasandzadeh, H., Ribeiro, T. P., Guerreiro, P. S., Gerhardt, E., Kröhnert, K., Klucken, J., Pereira, M. D., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004741 · Cited by 252 · see citing works

The role of the central ghrelin system in reward from food and chemical drugs

Dickson, S. L., Egecioglu, E., Landgren, S., Skibicka, K. P., Engel, J. A., & Jerlhag, E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.02.017 · Cited by 239 · see citing works

Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation.

Chung, H., Kim, E., Lee, D.-H., Seo, S., Ju, S., Lee, D., Kim, H., & Park, S. (2007) · Endocrinology · doi:10.1210/en.2006-0991 · Cited by 213 · see citing works

Neuroprotective Effect of Ghrelin in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson’s Disease by Blocking Microglial Activation

Moon, M., Kim, H. G., Hwang, L., Seo, J.-H., Kim, S., Hwang, S., Kim, S., Lee, D., Chung, H., Oh, M. S., et al. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9037-x · Cited by 203 · see citing works

Many faces of Parkinson's disease: non-motor symptoms of Parkinson's disease

Lee, H. M., & Koh, S.-B. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15003 · Cited by 191 · see citing works

Gastroparesis and Parkinson’s disease: a systematic review

Heetun, Z. S., & Quigley, E. M. M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.12.004 · Cited by 182 · see citing works

Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance

Scalzo, P., Kümmer, A., Cardoso, F., & Teixeira, A. L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.062 · Cited by 175 · see citing works

When does Parkinson's disease begin?

Gaig, C., & TOLOSA, E. S. (2009) · Movement Disorders · doi:10.1002/mds.22672 · Cited by 162 · see citing works

Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra

Arimoto, T., Choi, D., Lü, X., Liu, M., Nguyen, X. V., Zheng, N., Stewart, C. A., Kim, H., & Bing, G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.04.011 · Cited by 149 · see citing works

Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra

Jiang, H., Li, L.-J., Wang, J., & Xie, J.-X. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.006 · Cited by 144 · see citing works

Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3β and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen–glucose deprivation-induced apoptosis in primary rat cortical neuronal cells

Chung, H., Seo, S., Moon, M., & Park, S. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0160 · Cited by 143 · see citing works

Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats

Miao, Y., Xia, Q., Hou, Z., Zheng, Y., Pan, H., & Zhu, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.192 · Cited by 107 · see citing works

A rat model of Parkinson's disease induced by Japanese encephalitis virus

Ogata, A., Tashiro, K., Nukuzuma, S., Nagashima, K., & Hall, W. W. (1997) · Journal of NeuroVirology · doi:10.3109/13550289709015803 · Cited by 105 · see citing works

Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels

Shi, L., Bian, X., Qu, Z., Ma, Z., Zhou, Y., Wang, K., Jiang, H., & Xie, J. (2013) · Nature Communications · doi:10.1038/ncomms2439 · Cited by 103 · see citing works

Calorie-Restricted Weight Loss Reverses High-Fat Diet-Induced Ghrelin Resistance, Which Contributes to Rebound Weight Gain in a Ghrelin-Dependent Manner

Briggs, D. I., Lockie, S. H., Wu, Q., Lemus, M. B., Stark, R., & Andrews, Z. B. (2013) · Endocrinology · doi:10.1210/en.2012-1421 · Cited by 95 · see citing works

Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload

Jiang, H., Luan, Z., Wang, J., & XIE, J. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.04.015 · Cited by 81 · see citing works

Human Interleukin-10 Gene Transfer Is Protective in a Rat Model of Parkinson's Disease

Johnston, L. C., Su, X., Maguire‐Zeiss, K. A., Horovitz, K., Ankoudinova, I., Guschin, D. Y., Hadaczek, P., Federoff, H. J., Bankiewicz, K. S., & Forsayeth, J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.113 · Cited by 80 · see citing works

Insights into the Role of the Unusual Disulfide Bond in Copper-Zinc Superoxide Dismutase

Sea, K. W., Sohn, S. H., Durazo, A., Sheng, Y., Shaw, B. F., Cao, X., Taylor, A. B., Whitson, L. J., Holloway, S. P., Hart, P. J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.588798 · Cited by 80 · see citing works

Compartmentalized oxidative stress in dopaminergic cell death induced by pesticides and complex I inhibitors: Distinct roles of superoxide anion and superoxide dismutases

Rodríguez‐Rocha, H., García‐García, A., Pickett, C. S., Li, S., Jones, J., Chen, H., Webb, B., Choi, J. H., Zhou, Y., Zimmerman, M. C., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.021 · Cited by 77 · see citing works

Ghrelin Protects Alveolar Macrophages Against Lipopolysaccharide-Induced Apoptosis Through Growth Hormone Secretagogue Receptor 1a-Dependent c-Jun N-Terminal Kinase and Wnt/β-Catenin Signaling and Suppresses Lung Inflammation

Ли, Б., Zeng, M., He, W., Huang, X., Luo, L., Zhang, H., & Deng, D. Y. B. (2014) · Endocrinology · doi:10.1210/en.2014-1539 · Cited by 76 · see citing works

Assessments of plasma ghrelin levels in the early stages of Parkinson's disease

Song, N., Wang, W., Jia, F., Du, X., Xie, A., He, Q., Shen, X., Zhang, J., Rogers, J. T., Xie, J., et al. (2017) · Movement Disorders · doi:10.1002/mds.27095 · Cited by 67 · see citing works

Weight Loss and Impact on Quality of Life in Parkinson’s Disease

Akbar, U., He, Y., Dai, Y. E., Hack, N. K., Malaty, I. A., McFarland, N. R., Hess, C. W., Schmidt, P. N., Wu, S. S., & Okun, M. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124541 · Cited by 66 · see citing works

Ghrelin Antagonized 1-Methyl-4-Phenylpyridinium (MPP+)-Induced Apoptosis in MES23.5 Cells

Dong, J., Song, N., Xie, J.-X., & Jiang, H. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9162-7 · Cited by 64 · see citing works

The neurological effects of ghrelin in brain diseases: Beyond metabolic functions

Jiao, Q., Du, X., Li, Y., Gong, B., Shi, L., Tang, T., & Jiang, H. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.010 · Cited by 62 · see citing works

Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of Interleukin 10

Li, Q., Hong, J., & Flood, P. M. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_56 · Cited by 60 · see citing works

Unacylated as well as acylated ghrelin promotes cell survival and inhibit apoptosis in HIT-T15 pancreatic β -cells

Granata, R., Settanni, F., Trovato, L., Destefanis, S., Gallo, D., Martinetti, M., Ghigo, E., & Muccioli, G. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03347367 · Cited by 60 · see citing works

Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones

Beynon, A. L., Brown, M. R., Wright, R., Rees, M., Sheldon, I., & Davies, J. S. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-40 · Cited by 56 · see citing works

GI infections are associated with an increased risk of Parkinson’s disease

Nerius, M., Doblhammer, G., & Tamgüney, G. (2019) · Gut · doi:10.1136/gutjnl-2019-318822 · Cited by 56 · see citing works

Neuronal Expression of Familial Parkinson's Disease A53T α-Synuclein Causes Early Motor Impairment, Reduced Anxiety and Potential Sleep Disturbances in Mice

Rothman, S. M., Griffioen, K. J. S., Vranis, N. M., Ladenheim, B., Cong, W., Cadet, J.-L., Haran, J., Martin, B., & Mattson, M. P. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120130 · Cited by 49 · see citing works

Ghrelin Protects Spinal Cord Motoneurons Against Chronic Glutamate Excitotoxicity by Inhibiting Microglial Activation

Lee, S., Kim, Y., Li, E., & Park, S. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.1.43 · Cited by 41 · see citing works

Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model

Wang, W., Song, N., Jia, F., Tang, T., Bao, W., Zuo, C., Xie, J., & Jiang, H. F. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.01.006 · Cited by 38 · see citing works

Ghrelin Inhibits Oligodendrocyte Cell Death by Attenuating Microglial Activation

Lee, J. Y., & Yune, T. Y. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.3.371 · Cited by 37 · see citing works

1‐methyl‐4‐phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase

Barkats, M., Horellou, P., Colin, P., Millecamps, S., Biguet, N. F., & Mallet, J. J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20696 · Cited by 28 · see citing works

Lesion of medullary catecholaminergic neurons is associated with cardiovascular dysfunction in rotenone‐induced Parkinson's disease rats

Zhang, Z., Du, X., Xu, H., Xie, J., & Jiang, H. F. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.13012 · Cited by 25 · see citing works

Eradication of Helicobacter pylori Increases Ghrelin mRNA Expression in the Gastric Mucosa

Lee, E. S., Yoon, Y. S., Park, C., Kim, H.-S., Um, T. H., Baik, H. W., Jang, E. J., Lee, S. Y., Park, H. S., & Oh, S. W. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.2.265 · Cited by 23 · see citing works

Enhanced responsiveness of Ghsr Q343X rats to ghrelin results in enhanced adiposity without increased appetite

Chebani, Y., Marion, C., Zizzari, P., Chettab, K., Pastor, M., Korostelev, M., Gény, D., Epelbaum, J., Tolle, V., Morisset‐Lopez, S., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aae0374 · Cited by 23 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

Gastrodia elata polysaccharide alleviates Parkinson's disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota

Gan, Q., Peng, M., Wei, H., Chen, L., Chen, X.-Y., Li, Z.-H., An, G., & Ma, Y. (2024) · Food & Function · doi:10.1039/d3fo05169b · Cited by 57 · see citing works

The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases

Russo, C., Valle, M. S., Russo, A., & Malaguarnera, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113432 · Cited by 40 · see citing works

Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease

Bi, M., Du, X., Xiao, X., Dai, Y., Jiao, Q., Chen, X., Zhang, L., & Jiang, H. F. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102167 · Cited by 31 · see citing works

The potential roles of salivary biomarkers in neurodegenerative diseases

Jiao, L., Dong, H.-L., Liu, M.-M., Wu, P.-L., Cao, Y., Zhang, Y. E., Gao, F.-G., & Zhu, H.-Y. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106442 · Cited by 28 · see citing works

Update to the Treatment of Parkinson’s Disease Based on the Gut-Brain Axis Mechanism

Sun, X., Li, X., Wang, Z., & Xie, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.878239 · Cited by 26 · see citing works

Ghrelin Bridges DMV Neuropathology and GI Dysfunction in the Early Stages of Parkinson's Disease

Liu, Y., Wang, W., Song, N., Jiao, L., Jia, F., Du, X., Chen, X., Yan, C., Jiao, J., Jiao, Q., et al. (2022) · Advanced Science · doi:10.1002/advs.202203020 · Cited by 23 · see citing works

Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.

Jones-Tabah, J. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167927 · Cited by 18 · see citing works

Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections?

Mingardi, J., Meanti, R., Paoli, C., Cifani, C., Torsello, A., Popoli, M., & Musazzi, L. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22999240722095039 · Cited by 16 · see citing works

Astrocyte-derived apolipoprotein D is required for neuronal survival in Parkinson’s disease

Dai, Y., Bi, M., Jiao, Q., Du, X., Yan, C., & Jiang, H. F. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00753-8 · Cited by 12 · see citing works

Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons

Chen, L., Liu, C., Xue, Y., & Chen, X. (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102337 · Cited by 12 · see citing works

Beyond Hunger: The Structure, Signaling, and Systemic Roles of Ghrelin

Polishchuk, H., Guzik, K., & Kantyka, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210996 · Cited by 12 · see citing works

Neuropeptide apelin presented in the dopaminergic neurons modulates the neuronal excitability in the substantia nigra pars compacta

Liu, C., Kang, N.-W., Wang, Y., Xue, Y., Chen, X., & Chen, L. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109235 · Cited by 6 · see citing works

Fasting and postprandial Ghrelin levels in Parkinson’s disease: a systematic review and meta-analysis

Gouveia, H. J. C. B., dos Santos, O. H., & Frasnelli, J. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01066-0 · Cited by 5 · see citing works

Effects of Ghrelin Hormone on Alzheimer’s and Parkinson’s Disease: A Systematic Review of the Existing Literature

Abdulazeez, Y., Utami, R., Al-Jamal, K. T., & Mok, Z.-H. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00683 · Cited by 3 · see citing works

Ghrelin-based interventions in preclinical models of Parkinson’s disease: a systematic review

Gouveia, H. J. C. B., dos Santos, O. H., Frasnelli, J., Fisette, A., dos Santos, J. P., Araújo, M. A. D. S., da Silva‐Araújo, E. R., Toscano, A. E., & de Castro, R. M. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150187 · Cited by 2 · see citing works

The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy

Rodríguez-Ruiz, E. R., Herrero-Labrador, R., Fernández-Fernández, A. P., Serrano, J., Martínez-Montero, J. A., González‐Nieto, D., Vaish, M., Benchekroun, M., Ismaïli, L., Marco‐Contelles, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512254 · Cited by 2 · see citing works

An Integrated Approach on the Neuroprotective Effects of Ghrelin by Dietary Restriction: From AlphaFold Prediction, Molecular Simulation, to 6-OHDA Induced semi-Parkinson's Disease ModelPreprint

Shen, Z.-H., Ye, J.-X., Lin, S., Li, Z., Yan, X., Chen, T., Wan, C., Ye, T., & Fu, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-5426742/v1

Research Progress of Correlation between Parkinson’s Disease and Ghrelin and Leptin

Liu, J.-G. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141278

Early ghrelin intervention protects against the progressive dopaminergic neuron loss in Parkinson’s disease micePreprint

Jiao, L., Jia, F., Du, X., Zhang, P., Li, Y. H., Zhu, D., Tang, T., Jiao, Q., & Jiang, H. (2020) · doi:10.21203/rs.3.rs-19131/v1

Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson’s Disease

Rees, D. J., Beynon, A. L., Lelos, M. J., Smith, G. A., Roberts, L. D., Phelps, L., Dunnett, S. B., Morgan, A. H., Brown, M. R., Wells, T., et al. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01282-9 · Cited by 9 · see citing works

Neuroprotective Effect of Ghrelin on Substantia Nigra in Parkinson Disease Model Induced -MPTP

Nazif, N. N. (2019) · DOAJ (DOAJ: Directory of Open Access Journals)

Neuroprotective Effect of Ghrelin in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson’s Disease by Blocking Microglial Activation

Moon, M., Kim, H. G., Hwang, L., Seo, J.-H., Kim, S., Hwang, S., Kim, S., Lee, D., Chung, H., Oh, M. S., et al. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9037-x · Cited by 203 · see citing works

Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra

Jiang, H., Li, L.-J., Wang, J., & Xie, J.-X. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.006 · Cited by 144 · see citing works